Coronavirus (COVID-19) Vaccine Resources

There are three vaccines available in the U.S. The Pfizer-BioNTech vaccine is FDA-authorized for ages 12-15 and FDA approved for ages 16 and older. The Moderna^® and Johnson & Johnson^® vaccines are FDA-authorized for ages 18 and older.

A COVID-19 vaccine for children younger than 12 is not yet authorized but research is well underway. Pfizer^® and Moderna are both running large pediatric trials to study the effectiveness and safety of using their COVID-19 mRNA vaccines for children under 12.

If you are a parent or guardian with questions about the vaccine, we encourage you to talk with your child’s health care provider.

For more information you can read:

• The CDC director statement about the Pfizer-BioNTech COVID-19 vaccine
• The FDA decision to authorize emergency use of this vaccine in 12- through 15-year-old adolescents
• View CDC presentation slides

Cigna looks to the U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and input from the Advisory Committee on Immunization Practices (ACIP) to determine these factors.

It has been shown that all three COVID-19 vaccines currently available in the United States are highly effective at preventing COVID-19.

To learn more about the vaccines, visit:

Different COVID-19 Vaccines | CDC

Vaccines | FDA

The FDA recently authorized the use of Pfizer-BioNTech’s COVID-19 vaccine be administered as a booster shot at least six months after the completion of a second shot for certain populations. In addition, at this time, the CDC recommends that people with moderately to severely compromised immune systems receive an additional dose of the vaccine at least 28 days after a second dose of the Pfizer-BioNTech or Moderna vaccine. CDC also recommends that those 65 years of age receive a booster shot.

Research remains ongoing, but right now, the most important thing to remember is the current single or two-shot regimen continues to prevent severe illness in most vaccinated people, event against the Delta variant.

For the latest recommendations on eligibility of booster shots, including recommendations for the general population, refer to the CDC’s COVID-19 Vaccine Booster Shot or talk to your PCP.

Yes, you should be vaccinated regardless of whether you already had COVID-19 because:

• Research has not yet shown how long you are protected from getting COVID-19 again after you recover from COVID-19.
• Vaccination helps protect you even if you’ve already had COVID-19.

If you are in a position where you can choose your healthcare provider (e.g. non-emergency), we recommend using the provider directory available on myCigna.com or the myCigna^® mobile app to find an in-network provider. You can also call the phone number on your ID card to find in-network health care providers to eliminate any risk your provider may choose to bill above these rates.

Some people suffer from ongoing or new symptoms after a diagnosis of COVID-19. Recovery could take as long as or longer than 3 months. It is important to see your Primary Care Provider (PCP) to discuss ongoing COVID-19 symptoms and an appropriate treatment plan. If you don’t have a PCP, log in to myCigna and use the provider directory to find an in-network provider. For more information, visit Post-COVID Conditions | CDC

After you recover from COVID-19 and/or return home from a hospitalization, your PCP can determine the best treatment plan, including assessing any follow care needed. Continue to take ensure you are up to date with preventative care screenings.

The FDA recently authorized the monoclonal antibody therapy, REGEN-COV^TM, for emergency use as post-exposure prevention of COVID-19 for those 12 years of age and older weighing at least 88 pounds who are at high risk for progression to severe COVID-19, including hospitalization or death.

REGEN-COV also remains authorized for the treatment of mild-to-moderate COVID-19 for those who are at high-risk for progression to severe COVID-19. Your PCP is the best person to discuss whether this therapy is appropriate for you.

To find locations that may be able to provide monoclonal antibody therapeutic treatments visit:

The U.S. Department of Health and Human Services (HHS) outpatient antibody treatment locator tool

The National Infusion Center Association^SM